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Abstract 
It is generally accepted that in frog full-grown oocytes glycolysis is absent and that carbon metabolic flux is largely directed to glycogen synthesis. 
Use of an anion exchange pellicular resin for analytical resolution of intermediates in perchloric acid extracts of oocytes has allowed us to observe 
the formation of labelled lactate after microinjection of [u-i4C]glucose. Further, formation of [“P]ATP was observed after microinjection of 
32P-labelled glucose-6-P, fructose-6-P or fructose-1,6-b&P, either in the presence or absence of 0.1 mM cyanide. The presence of phosphofructokinase 
activity, previously thought to be absent in oocytes, is also reported. These findings indicate that glycolysis to lactate is operative in frog oocytes. 
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1. Introduction 
Present views of carbon metabolism in oocytes and 
early amphibian embryos hold that they are largely gly- 
cogenic and that glycolysis is not operative in these cells 
(see [l] for a review). These conclusions stem from exper- 
iments showing that: (i) microinjection of [32P]PEP1 does 
not result in ATP labelling but instead in the rapid 
appearance of the radioactivity in glucose-6-P and/or 
glucose-l-P, and later UDP-glucose [2]; (ii) In vivo inhi- 
bition of glyceraldehyde-3-P dehydrogenase activity by 
iodoacetamide or iodoacetate or treatment of the cells 
with dinitrophenol results in the formation of [32P]ATP 
from [32P]PEP [2]. It was then concluded that oocyte 
pyruvate kinase is normally inactive in vivo but that 
conditions which inhibit glycogenic flux are able to acti- 
vate the enzyme and, therefore, glycolysis. Likewise, re- 
ports from our laboratory [3] and others [4] have shown 
that after microinjection of [l-14C]- or [6-i4C]-glucose, 
14C02 production is observed only with the former, a 
result which is consistent with the view that glycolysis is 
inactive in oocytes. Further, measurements of enzyme 
activities in homogenates showed that pyruvate kinase is 
very active whereas PFK activity was very low or absent 
[5]. The recent availability of a protocol for the analytical 
separation and identification of intermediates of glucose 
utilization [6] has permitted the aquisition of the new 
evidence reported in this article, indicating that [14C]lac- 
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tate and [32P]ATP are produced in frog oocytes after 
microinjection of [14C]glucose or 32P-labelled hexoses-P, 
respectively. The conclusion that glycolysis to lactate is 
operative in amphibian stage VI oocytes is important 
because it provides a proper reference to understand 
changes of energy metabolism during differentiation of 
these cells. 
2. Materials and methods 
2.1. Materials 
Labelled compounds were from the Radiochemical Centre (Amer- 
sham). Before the experiment, aliquots were dried under N2 to remove 
ethanol, carrier solutions were added, and resuspended in saline to 
achieve the desired concentration. Auxiliary enzymes, ATP and NAD’ 
were mostly from Sigma. Mixtures for scintillation counting were from 
New England Nuclear. 
2.2. Microinjection procedures and metabolic labelling 
Oocytes (stage VI) from the frog Caudiverbera caudiverbera were 
used because of its local availability but mainly because its volume 
(about 3 ,ul, compared to the 1~1 Xenopus cells) which allows analysis 
of single oocytes instead of pooled cells. Nonetheless, afew experiments 
with Xenopus oocytes showed the same results (not shown). Injection 
techniques and handling of compounds were as described [5]. Briefly, 
approximately 50 nl of mod&d Barth saline [7] containing radioactive 
glucose (or other compounds) were injected. Groups of 5 oocytes were 
then incubated at 22°C under 100% Oa. After incubation, cells were 
frozen in liquid N,, homogenized in cold 3% PCA and neutralized. 
After centrifugation, glycogen was discarded by ethanol precipitation 
and the supernatant fraction lyophilized and stored until analysis. 
2.3. Separation of metabolic intermediates by ionic exchange 
chromatography 
Separation and identification of metabolites was essentially as de- 
scribed [6]. Aliquots of lyophilized PCA extracts were submited to 
chromatograhy on a CarboPac PA1 column [8,9] controlled by a high 
performance liquid chromatography apparatus (LKB). The column 
was equilibrated with 100% solution A (50 mM NaOH) and 0% solu- 
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tion B (1 M sodium acetate in 100 mM NaOH) and operated at a flow 
rate of 0.5 mUmin with a gradient program as follows: To = 0%, r, = 
0%, T,, = lo%, r, = 15%, I”,, = 2096, T,, = 50%, Th5 = 50%, TM = 100% 
(subscript numbers are time in minutes, percent figures refer to amount 
of solution B). Radioactivity readings were taken every 30 s by an on 
line Beckman 171 Radioisotope detector. Readings were processed with 
the ChromatoGraphics program supplied by Beckman. Labelled inter- 
mediates were identified by comparison of retention times with those 
of authentic commercial compounds, by spiking of the samples with 
authentic compounds or by incubation of PCA samples with specific 
enzymes [6]. 
2.4. Enzymatic ident@cation of lactate 
An aliauot (containing anroximatelv 100.000 cnm) of a PCA extract 
from [U-i4C]iucose-inj&&d oocytes &as incubaied’4 h at 37°C in an 
assay mixture containing: 50 mM Bicine pH 9.4,40 mM glutamic acid, 
5 mM NAD+, 4 units of glutamic-pyruvic transaminaae, 27.5 units of 
lactic dehydrogenase in a 6nal volume of 100 ~1. The reaction was 
stopped by addition of 100 mM NaOH, the sample was spun and 
chromatographed as described. The elution time of an internal standard 
of [3H]alanine was compared with that of the enzymatic product. The 
production of alanine by the enzyme system was checked in a parallel 
experiment using [‘4C]lactate as substrate. 
2.5. [3zP]fructosed-P synthesis 
1 mM unlabelled fructose was mixed with 0.1 mM unlabelled ATP, 
200 ,&i [r-“P]ATP, 100 mM Tris, pH 8.0, 5 mM MgCl, and 3.8 units 
of yeast hexokinase in a total volume of 50 ~1. After 30 min incubation 
at room temperature the reaction was stopped by heating during 4 min 
at 95°C. After spinning, the supematant was used as the labelled sub- 
strate, which was analyzed by HPLC on a CarboPac PA1 column prior 
to the experiments. 
2.6. PFK activity 
10 g of oocytes were homogenized in 7 ml of 20 mM Tris buffer, 
pH 7.5, containing 2 mM MgCl,, 1 mM D’lT, 0.1 mM EDTA, 1 PM 
pepstatin and 0.1 mM phenyhnethylsulfonyl fluoride. After centrifuga- 
tion at 40,000 rpm for 1 h the supematant fraction was applied to a 
DEAE-cellulose column equilibrated in the same buffer. The column 
was washed with 5 volumes of the buffer and the enzyme eluted with 
100 mM KCl. Enzyme activity was determined by the coupled assay of 
Racker [lo] in a Hewlett Packard 8452A Diode array spectrophotome- 
ter. The assay mixture contained 0.1 M Tris-HCl pH 8.2, 1 mM DTT, 
0.2 mM NADH, 2 mM NH,Cl, 1 mM fructose-6-P, 1 mM ATP, 10 mM 
MgCl, and a mixture of 40 pg aldolase, 3 fig of triose phosphate 
isomerase and 30 pg of a-glycerophosphate d hydrogenase ina volume 
oflml. 
3. Results and discussion 
3.1. Separation and identzfication of labelled 
intermediates after [ U-14C]glucose microinjection 
Chromatography of PCA extracts from oocytes mi- 
croinjected with [U-14C]glucose showed several radioac- 
tive peaks of intermediates (Fig. 1A). Criteria for identi- 
fication were both coelution with authentic commercial 
compounds and specific enzymatic treatments prior to 
chromatography [6]. Identified intermediates are glu- 
cose-l-P, glucose-6-P, fructose-6-P, and fructose-1,6-bis- 
P. An additional fraction (designed as X) was also ob- 
served and will be dealt with below. 
The appearance of these intermediates uggests that 
glucose is metabolized through the Embden-Meyerhof 
pathway but the suggestion would be strengthened by the 
observation of labelled pyruvate and/or lactate from mi- 
croinjected [U-14C]glucose. Therefore we sought the 
presence of either lactate or pyruvate in fraction X. 
Treatment of a neutralized PCA extract with lactic dehy- 
drogenase and alanine aminotransferase followed by 
chromatography in the CarboPac PA1 column (Fig. 1 B), 
moves about 65% of the radioactivity associated with 
fraction X to a different elution time (13 min) which 
corresponds to that of authentic labelled alanine. Con- 
trol experiments with heat inactivated enzymes or with 
NADC omitted from the reaction mixture did not show 
labelled alanine (data not shown). The presence of lac- 
tate in a purified preparation of fraction X was also 
confirmed by mass spectrometry (not shown). Experi- 
ments in progress suggest he presence of trioses phos- 
phate in the minor unreacted portion of fraction X. Ra- 
dioactivity in lactate after 5 min of incubation accounts 
for 68% of the total label microinjected but higher 
amounts have been observed at shorter times. 
3.2. ATP formation in oocytes after [32P]phosphoryl- 
hexoses microinjection 
Another criterion for glycolytic activity is ATP pro- 
duction from 32P-labelled glycolytic intermediates. 
Dworkin and Dworkin-Rastl [1,2] reported lack of 
[32P]ATP formation in Xenopus oocytes after injection of 
[32P]PEP, a result which they ascribed to a block of py- 
ruvate kinase activity in vivo. We have studied this prob- 
lem by microinjection of [32P]phosphoryl-hexoses and 
detection of [32P]ATP production by chromatography in 
the CarboPac column described above. Labelled fruc- 
tose-6-P microinjected into oocytes produces a radioac- 
tive peak of ATP (eluting at min 73) after one minute that 
continues to increase up to 16 min, the longest time 
studied (Fig. 2). Other radioactive peaks were also ob- 
served and most of them identified as shown in Fig. 2. 
The same results were observed in oocytes co-injected 
with 0.1 mM cyanide and labelled fructose-6-P (not 
shown) indicating that [32P]ATP production results 
from the operation of the glycolytic pathway rather than 
from oxidative phosphorylation. Oxygen consumption 
was completely inhibited in the presence of cyanide. 
Control oocytes showed a value of oxygen consumption 
of approximately 0.18 nmol/min/oocyte, very similar 
to the one reported by Cicirelli and Smith [4] for Xenopus 
oocytes. 
Fig. 2 shows that microinjected [32P]fructose-6-P is
rapidly converted into labelled glucose-6-P (already at 5 
s, the minimum time between injection and freezing). 
Minor peaks of fructose-1,6-bis-P and ATP are also vis- 
ible at this time. At 1 min, Pi, glucose-l-P and 6-P-glu- 
conate appears and the ATP peak increases. Between 4 
and 16 min, the ATP peak has reached a maximum and 
has split into two peaks. The most retained peak is so far 
unidentified. Oocytes injected with [32P]glucose-6-P or
[ 1 -32P]fructose-l ,6-bis-P, showed essentially the same be- 
havior with respect o ATP production (data not shown). 
3.3. Presence of PFK activity in frog oocytes 
Reports from our laboratory [5] and others (for refer- 
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Fig. 1. The presence of lactate among intermediates of glucose utilization in frog oocytes microinjected with [u-‘Qglucose. Oocytes were microin- 
jetted with a saline sohttion containing 0.5 nmol of labelled ghrcose (about 50,000 cpm). After 5 min of incubation at room temperature, PCA extracts 
were pmpared and processed as indicated in section 2. An aliquot of 70 ,uI was immediately c~to~ap~ (A). Another aliquot was used for enzymatic 
identification of lactate as described in section 2 (B). Both samples were chromatography for separation of intermediates in a CarboPac PA1 column. 
Identified compounds are marked. X refers to a peak containing lactate which is converted to alanine in the experiment depicted in panel B. 
ences see [ 11) have suggested the absence of PFK activity 
in stage VI oocytes. However, the formation of labelled 
lactate after @-r4C]glucose microinjection suggests that 
this is not the case. The problem was reinvestigated by 
measurement of PFK activity in concentrated oocyte 
extracts in the presence of protease inhibitors. Values of 
about 4 milliunits of PFK activity per gram of oocyte 
were found, which are indeed very low compared with 
the activity of other enzymes involved in glucose utiliza- 
tion in these cells [S]. Moreover, some preparations were 
devoid of detectable nzyme activity. These results could 
explain the absence of PFK activity previously reported 
in these cells. Using a DEAE-cellulose semipurified en- 
zyme preparation we observed a hyperbolic saturation 
curve with respect to fructose-6-P at pH 8 and 1 mM 
ATP. The apparent rim value for fructose-6-P was 0.2 
mM. Due to the very low activity of the preparations it 
was not possible to study saturation curves at neutral 
PH. 
As reported in previous papers by our group [3,&l l] 
or by other workers [1,2,12,13], frog oocytes metabolize 
glucose to glycogen and, to a minor extent, through the 
pentose-P pathway. However, as shown in this report, 
glucose is also degraded to lactate with the concomitant 
production of ATP The fate of lactate produced from 
glucose is unknown but further breakdown through the 
citric acid cycle can be ruled out since we [5] and others 
[4] have never observed 14C02 production from [6- 
“C]glucose. The absence of ATP labelling from microin- 
jetted [32P]PEP reported by Dworkin and Dworkin-Rastl 
[1,2] may be explained by the very low amount of injected 
substrate (0.2 pmol per oocyte) or by the poor resolution 
of the thin layer chromatography method used for sepa- 
ration of intermediates in their experiments. Also, differ- 
ent species (X. Levis vs. C. caudiverbera) were used but, 
as mentioned earlier, a few experiments performed with 
Xmopus oocytes gave essentially the same results as 
those in Caudiverbera. 
Although it is well established that glycogen is the 
main product of glucose metabolism in frog oocytes, the 
experiments presented in this report show a considerable 
flow of carbon to lactate during the first ~nutes after 
glucose microinjection. Likewise, phosphate from in- 
jected fructose-6-P is transferred to ATP which implies 
the use of the carbohydrate moiety in glycolysis instead 
of glycogen synthesis. These facts are at variance with 
the accepted view that polysaccharide synthesis directly 
starts from glucose-6-P derived from glucose phospho- 
rylation, Although the details of lactate utilization by 
oocytes have not yet assessed, the lack of 14C02 produc- 
tion from [6-14C]glucose r nders an oxidative metabo- 
lism of lactate unlikely and would favor the assumption 
that it is finally converted into glycogen through the 
gluconeogenic pathway. The ~~~~~g of the bene- 
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Fig. 2. ATP production in frog oocytes microinjected with [32P]fructose-6-P. Oocytes were microinjected with 50 nl of saline solution containing 0.1 
nmol of labelled fructose-6-P (about 200,000 cpm). After incubation at the indicated times, PCA extracts were prepared and processed in a CarboPac 
column. Identified compounds are marked but, for the sake of simplicity, the labels are indicated only in a few cases. 
fits of such an ‘indirect’ pathway of glycogen formation 
from glucose needs a better knowledge of oocyte meta- 
bolic organization than is presently available. Since the 
interpretation of tracer experiments performed in a sin- 
gle cell is easier than in multicellular systems (because of 
the possibility of compartmentation between cells), 
oocytes provide a useful model for this kind of experi- 
ments. 
Finally, we would like to stress that the results pre- 
sented in this report should emphasize the importance of 
detailed metabolic studies in frog oocytes vis-a-vis the 
present widespread use of these cells for the analysis of 
almost any kind of problem in cell biology. 
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